• Users Online: 334
  • Print this page
  • Email this page

    Article Cited by others


Liposomes as potential nanocarriers for theranostic applications in chronic inflammatory lung diseases

Suer Hande, Bayram Hasan

Year : 2017| Volume: 1| Issue : 1 | Page no: 1-8

   This article has been cited by
1 Prospective nanoparticle treatments for lymphangioleiomyomatosis
Emelie Landh, Roger Wang, Lyn M. Moir, Daniela Traini, Paul M. Young, Hui Xin Ong
Expert Opinion on Drug Delivery. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections
James D. Chalmers,Jakko van Ingen,Roald van der Laan,Jean-Louis Herrmann
European Respiratory Review. 2021; 30(161): 210010
[Pubmed]  [Google Scholar] [DOI]
3 A Phospholipid-Based Formulation for the Treatment of Airway Inflammation in Chronic Respiratory Diseases
Varsha Komalla,Venkata Sita Rama Raju Allam,Philip Chi Lip Kwok,Behjat Sheikholeslami,Louisa Owen,Adam Jaffe,Shafagh A Waters,Shiva Mohammad,Brian Gregory Oliver,Hui Chen,Mehra Haghi
European Journal of Pharmaceutics and Biopharmaceutics. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article